Document Detail


Thrombocytosis--report of a case.
MedLine Citation:
PMID:  11273186     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Thrombocytosis is a common clinical condition. Drugs used for thrombocytosis are hydroxy urea, alkylating agents and interferon alpha. We are reporting a case of chronic myeloid leukemia with thrombocytosis who did not respond to hydroxy urea but was controlled with the addition of a new drug anagrelide. Anagrelide is a platelet reducing agent with no serious side effects. It may be the main weapon against thrombocytosis associated with chronic myeloid leukaemia (CML) and essential thrombocytosis in the coming years.
Authors:
M Thomas; K Pavithran; Salil; A Somarajan
Related Documents :
21926436 - Model reference adaptive scheme for multi-drug infusion for blood pressure control.
22001536 - Multifunctional silica nanoparticles for targeted delivery of hydrophobic imaging and t...
73316 - Azapropazone induced bullous drug eruptions.
22200596 - An alternative synthetic route for an antidiabetic drug, rosiglitazone.
3301706 - Oral contraceptives in the united states: trends in content and potency.
17971226 - Medicinal importance of grapefruit juice and its interaction with various drugs.
Publication Detail:
Type:  Case Reports; Journal Article    
Journal Detail:
Title:  The Journal of the Association of Physicians of India     Volume:  48     ISSN:  0004-5772     ISO Abbreviation:  J Assoc Physicians India     Publication Date:  2000 Apr 
Date Detail:
Created Date:  2001-03-01     Completed Date:  2001-04-12     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  7505585     Medline TA:  J Assoc Physicians India     Country:  India    
Other Details:
Languages:  eng     Pagination:  441-2     Citation Subset:  IM    
Affiliation:
Department of Internal Medicine and Haematology, Medical College Hospital, Trivandrum-695 011.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Aged
Antineoplastic Agents / therapeutic use
Female
Humans
Hydroxyurea / therapeutic use
Leukemia, Myelogenous, Chronic, BCR-ABL Positive / complications,  drug therapy
Platelet Aggregation Inhibitors / therapeutic use*
Platelet Count
Quinazolines / therapeutic use*
Thrombocytosis / drug therapy*,  etiology
Chemical
Reg. No./Substance:
0/Antineoplastic Agents; 0/Platelet Aggregation Inhibitors; 0/Quinazolines; 0/anagrelide; 127-07-1/Hydroxyurea

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Subdural haematoma with spontaneous resolution--rare manifestation of idiopathic thrombocytopenic pu...
Next Document:  Diagnostic dilemma: aspergillosis.